COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Sep. 30, 2021	Mar. 31, 2021
Weighted Average Discount Rate Operating Lease	9.09%		9.09%
Additional Deposit Amount					$ 1,900,000	$ 200,000
Increase In Right Of Use Asset And Liability			$ 1,100,000
Operating Lease Liabilities	$ 2,100,000		2,100,000
Research And Development Expenses			35,500,000
Operating Lease Right Of Use Assets	1,900,000		1,900,000		2,100,000
Current Balance	200,000		200,000		100,000
Net Of Discount			11,800,000
Operating Lease Expense	$ 91,000	$ 66,000	272,000	$ 198,000
Operating Lease Payment			$ 199,000	176,000
Weighted Average Time To Maturity			9 years
Landlord [Member]
Interest Rate	8.45%		8.45%
Lease Description			The repayment includes a base rent which escalates at 3% each year plus interest that accrues at 13.75% per year
Financing Arrangement			$ 11,100,000
Payments Made By Landlord			$ 2,400,000
October 1, 2019 [Member] | Transaction One [Member]
Weighted Average Time To Maturity			6 years 3 months 18 days
Weighted Average Discount Rate	8.45%		8.45%
Net Book Value Of The Finance Lease Right Of Use Asset	$ 11,400,000		$ 11,400,000		12,700,000
Balance Of The Finance Lease Liability	13,600,000		13,600,000		$ 13,800,000
Cash Paid Related To Finance Leases			1,900,000	1,600,000
Cash Paid Related To Finance Leases Interest			900,000
Ergomed [Member]
Research And Development Expenses	$ 100,000	$ 400,000	500,000	$ 1,400,000
Clinical Service Trial			$ 12,000,000